+ Watch IMUC
on My Watchlist
It is going to hit 6 dollars by the end of 2014. Biotechnology is on the rise.
according to the company, we can expect results from the ict-107 phase II trail.
several good products progressing in the pipeline.
Strong pipeline. low requirement for approval. Just needs to "same or better" then current treatments for GBMF (Brain cancer). and current treatment is frankly poor. Chance of no approval is almost zero.
Research in pipeline
It was picked by www.hechtsoft.de Trade Alerts.
Has a cancer vaccine that appears very promising.
Definitely speculative, but I figure the technology is interesting and some bright phase one clinical trial results are enough for me to take the risk
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions